文献速递神经肿瘤

BRD4通过上调PD-L1表达促进胶质瘤细胞的免疫逃逸

BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression.
PubMed 文献 · J Neurooncol · 2024-11-28

研究利用TCGA和CGGA数据库分析BRD4表达与胶质瘤患者生存的关系,并通过体外实验和GL261小鼠颅内荷瘤模型探究BRD4对胶质瘤增殖、侵袭、迁移及PD-L1表达的调控作用。结果显示BRD4高表达与高级别胶质瘤患者生存期差相关,BRD4在转录水平调控PD-L1,敲低BRD4可抑制肿瘤生长并减少免疫抑制。

要点

  • BRD4在高级别胶质瘤中表达升高,且与患者生存期差相关。
  • BRD4在转录水平调控PD-L1表达,参与胶质瘤免疫逃逸。
  • 小鼠颅内模型中敲低BRD4可抑制肿瘤生长并减轻免疫抑制。

核心结论

  • BRD4能够调控胶质母细胞瘤的生长,并通过促进PD-L1表达增强免疫抑制。
  • 靶向BRD4是未来研究和治疗的一个有前景的方向。

研究设计与样本

  • 基于TCGA和CGGA数据库进行BRD4基因表达与生存分析。
  • 体外采用克隆形成实验、Transwell实验、CCK8实验和伤口愈合实验检测BRD4对胶质瘤细胞增殖、侵袭和迁移的影响。
  • 采用染色质免疫沉淀(ChIP)实验确认BRD4与PD-L1启动子的结合。
  • 将携带BRD4 shRNA和/或PD-L1 cDNA的GL261细胞颅内注射至小鼠,观察肿瘤生长和生存时间。
  • 采用H&E和免疫组化(IHC)染色分析肿瘤组织特征,采用流式细胞术评估免疫细胞浸润。

主要发现

  • 高级别胶质瘤中BRD4表达升高与患者生存期差相关。
  • BRD4对胶质瘤细胞增殖、侵袭和迁移具有促进作用。
  • ChIP实验结果显示BRD4是PD-L1的转录水平调控因子。
  • 体内研究显示敲低BRD4可抑制肿瘤生长、减少免疫抑制并改善预后。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Glioblastoma multiforme (GBM) poses significant challenges in treatment due to its aggressive nature and immune escape mechanisms. Despite recent advances in immune checkpoint blockade therapies, GBM prognosis remains poor. The role of bromodomain and extraterminal domain (BET) protein BRD4 in GBM, especially its interaction with immune checkpoints, is not well understood. Our study aimed to explore the role of BRD4 in GBM, especially the immune aspects. METHODS: In this study, we performed bioinformatics gene expression and survival analysis of BRD4 using TCGA and CGGA databases. In addition, we investigated the effects of BRD4 on glioma cell proliferation, invasion and migration by clone formation assay, Transwell assay, CCK8 assay and wound healing assay. Chromatin immunoprecipitation (ChIP) assay was conducted to confirm BRD4 binding to the programmed death ligand 1 (PD-L1) promoter. GL261 cells with BRD4 shRNA and/or PD-L1 cDNA were intracranially injected into mice to investigate tumor growth and survival time. Tumor tissue characteristics were analyzed using H&E and IHC staining and immune cell infiltration were assessed by flow cytometry. RESULTS: The results showed that elevated expression of BRD4 in high-grade gliomas was associated with poor patient survival. In addition, we validated the promotional effects of BRD4 on glioma cell proliferation, invasion and migration. The results of ChIP experiments showed that BRD4 is a regulator of PD-L1 at the transcriptional level, implying that it is involved in the immune escape mechanism of glioma cells. In vivo studies showed that BRD4 knockdown inhibited tumor growth and reduced immunosuppression, improving prognosis. CONCLUSION: BRD4 has the capability to regulate the growth of glioblastoma and enhance immune suppression by promoting PD-L1 expression. Targeting BRD4 represents a promising direction for future research and treatment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Cai L, Wang H, et al. BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression. J Neurooncol. 2024. PMID: 39607572. doi:10.1007/s11060-024-04889-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。